Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries
|Publication Date:||15 October 2018|
Implements Reference (a) by establishing policy and assigning responsibilities governing coordination and management of medical research efforts and DoD programs related to prevention, mitigation, and treatment of blast injuries.
Designates the Secretary of the Army, in compliance with Reference (a) and consistent with Reference (b), as the DoD Executive Agent (DoD EA) for Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries according to Reference (b).
Establishes the Armed Services Biomedical Research Evaluation and Management (ASBREM) Committee. The ASBREM Committee serves to facilitate coordination and prevent unnecessary duplication of effort within DoD biomedical research and development and associated enabling research areas, to include serving as the forum for implementation of subsections (d) and (g) of Reference (a).
This Directive applies to:
The Office of the Secretary of Defense, the Military Departments, the Chairman of the Joint Chiefs of Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities in the Department of Defense (hereafter collectively referred to as the "DoD Components").
Medical and associated enabling research supported by any DoD Component for prevention, mitigation, and treatment of blast injuries.